Imagine a world where heart transplants do not cost that much and do not have long waiting lists. Imagine not having to go through immunosuppressive therapy following a life and death surgery. Fortunately, we won’t have to imagine these soon as BIOLIFE4D is already developing a technology that could eliminate these concerns and do more for people with heart diseases and abnormalities.
BIOLIFE4D is currently developing a technology, a bioprinter, that would allow medical professionals and scientists to 3D print a human heart, which can then be transplanted to a patient who is in dire need of help. The company’s solution involves harvesting iPS cells or induced pluripotent stem cells. The adult specialized cells will be subjected to a process called differentiation in order for them to become specialized cardiac cells, which will serve as the building blocks of the bioprinted heart.
To read the full article from International Business Times, please click here.